Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (22)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Dor, J.
Right arrow Articles by Rabinovici, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dor, J.
Right arrow Articles by Rabinovici, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 15, No. 6, 1225-1230, June 2000
© 2000 European Society of Human Reproduction and Embryology

Effects of gonadotrophin-releasing hormone agonists on human ovarian steroid secretion in vivo and in vitro—results of a prospective, randomized in-vitro fertilization study

J. Dor1, D. Bider, A. Shulman, J. Levron, S. Shine, S. Mashiach and J. Rabinovici

IVF Unit, Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Tel Hashomer, Israel

The aim of this prospective randomized study was to compare the effects of two gonadotrophin-releasing hormone (GnRH) agonists, buserelin and triptorelin, on human ovarian follicular steroidogenesis, oocyte fertilization and IVF treatment outcome. Ovulatory, healthy women undergoing IVF were treated either with human menopausal gonadotrophin (HMG) alone or with HMG and one of the two GnRH agonists. Serum and follicular fluid hormonal concentrations and cultures of luteinizing granulosa cells obtained during follicular aspiration were analysed. GnRH agonist treatment significantly affected steroidogenesis both in serum and follicular fluid. In follicular fluid, progesterone and oestradiol concentrations were significantly elevated while testosterone concentrations were significantly lower in the triptorelin group. The ratios of testosterone/progesterone, oestradiol/progesterone but not oestradiol/testosterone concentrations were significantly affected by GnRH agonist administration. Similarly, the steroidogenic activity of luteinizing granulosa cells in vitro was significantly decreased in women treated with GnRH agonists. Women treated with GnRH agonists had significantly more fertilized oocytes and cleaving embryos. The results indicate a marked effect of GnRH agonists on the pattern of ovarian follicular steroidogenesis that cannot be explained solely by changes in gonadotrophin concentrations.

Key words: GnRH agonists/granulosa cells/IVF/ovary/steroidogenesis

1 To whom correspondence should be addressed at: IVF Unit, Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Tel Hashomer, Israel. E-mail: jehoshua{at}netvision.net.il


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Reproductive SciencesHome page
C. Metallinou, B. Asimakopoulos, A. Schroer, and N. Nikolettos
Gonadotropin-Releasing Hormone in the Ovary
Reproductive Sciences, December 1, 2007; 14(8): 737 - 749.
[Abstract] [PDF]

Home page
 Hum ReprodHome page
L. Safdarian, F. S. Mohammadi, A. Alleyassin, M. Aghahosseini, A. Meysamie, and E. Rahimi
Clinical outcome with half-dose depot triptorelin is the same as reduced-dose daily buserelin in a long protocol of controlled ovarian stimulation for ICSI/embryo transfer: a randomized double-blind clinical trial (NCT00461916)
Hum. Reprod., September 1, 2007; 22(9): 2449 - 2454.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
C. K. Cheng and P. C. K. Leung
Molecular Biology of Gonadotropin-Releasing Hormone (GnRH)-I, GnRH-II, and Their Receptors in Humans
Endocr. Rev., April 1, 2005; 26(2): 283 - 306.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
J. A. Garcia-Velasco, V. Isaza, C. Vidal, A. Landazabal, J. Remohi, C. Simon, and A. Pellicer
Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix)
Hum. Reprod., December 1, 2001; 16(12): 2533 - 2539.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. K. Miller
Androgen Deficiency in Women
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2395 - 2401.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
O. Ortmann, J.M. Weiss, and K. Diedrich
Embryo implantation and GnRH antagonists: Ovarian actions of GnRH antagonists
Hum. Reprod., April 1, 2001; 16(4): 608 - 611.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. K. Miller, G. Sesmilo, A. Schiller, D. Schoenfeld, S. Burton, and A. Klibanski
Androgen Deficiency in Women with Hypopituitarism
J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 561 - 567.
[Abstract] [Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.